Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Munkvad

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1990
Plasma HMW fibrinogen in patients with ischaemic heart diseaseS Munkvad, W Nieuwenhuizen, J Jespersen
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1991
Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled studyS Munkvad, J Gram, J Jespersen
Acta Dermato-Venereologica|July 1, 1994
Low anti-streptokinase IgG concentrations following streptokinase-streptodornase treatment of leg ulcer patientsS Munkvad, L Breuning, J Tvedskov
American Journal of Obstetrics and Gynecology|July 1, 1990
Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogenJ Gram, S Munkvad, J Jespersen
Lymphokine and Cytokine Research|August 1, 1991
Interleukin-1 and tumor necrosis factor-alpha in plasma of patients with acute ischemic heart disease who undergo thrombolytic therapy: a randomized, placebo-controlled studyS Munkvad, J Gram, J Jespersen
Ugeskrift for Laeger|September 26, 1988
[Thrombosis-precipitating factors and diagnosis in a patient with qualitative antithrombin III defect]S Munkvad, J Gram, J Jespersen
Danish Medical Bulletin|September 1, 1993
The fibrinolysis and coagulation systems in ischaemic heart disease. Risk markers and their relation to metabolic dysfunction of the arterial intimaJ Jespersen, S Munkvad, J B Gram
Agents and Actions. Supplements|January 1, 1992
Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarctionC Kluft, S Munkvad, J Gram, et al.
Acta Dermato-Venereologica|October 21, 1998
CO2 laser eradication of recalcitrant condyloma acuminatum does not influence T-lymphocyte subsetsC S Petersen, S Munkvad, C B Christiansen
Clinical Chemistry|July 1, 1990
Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasmaS Munkvad, J Jespersen, J Sidelmann, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1990
Plasma HMW fibrinogen in patients with ischaemic heart diseaseS Munkvad, W Nieuwenhuizen, J Jespersen
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1991
Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled studyS Munkvad, J Gram, J Jespersen
Acta Dermato-Venereologica|July 1, 1994
Low anti-streptokinase IgG concentrations following streptokinase-streptodornase treatment of leg ulcer patientsS Munkvad, L Breuning, J Tvedskov
American Journal of Obstetrics and Gynecology|July 1, 1990
Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogenJ Gram, S Munkvad, J Jespersen
Lymphokine and Cytokine Research|August 1, 1991
Interleukin-1 and tumor necrosis factor-alpha in plasma of patients with acute ischemic heart disease who undergo thrombolytic therapy: a randomized, placebo-controlled studyS Munkvad, J Gram, J Jespersen
Ugeskrift for Laeger|September 26, 1988
[Thrombosis-precipitating factors and diagnosis in a patient with qualitative antithrombin III defect]S Munkvad, J Gram, J Jespersen
Danish Medical Bulletin|September 1, 1993
The fibrinolysis and coagulation systems in ischaemic heart disease. Risk markers and their relation to metabolic dysfunction of the arterial intimaJ Jespersen, S Munkvad, J B Gram
Agents and Actions. Supplements|January 1, 1992
Variable depletion of endogenous factor XII-dependent fibrinolytic activity following thrombolytic therapy of myocardial infarction and its relation to reinfarctionC Kluft, S Munkvad, J Gram, et al.
Acta Dermato-Venereologica|October 21, 1998
CO2 laser eradication of recalcitrant condyloma acuminatum does not influence T-lymphocyte subsetsC S Petersen, S Munkvad, C B Christiansen
Clinical Chemistry|July 1, 1990
Specific, sensitive, precise, and rapid functional chromogenic assay of activated first complement component (C1) in plasmaS Munkvad, J Jespersen, J Sidelmann, et al.
Pageof 4